Fundz

Integer Holdings Corporation

Plano, Texas, United States · Biotechnology, Healthcare, Health Care

Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets.

Key facts

Headquarters
Plano, Texas, United States
Employees
11,000
Industries
Biotechnology, Healthcare, Health Care
Status
Public (ITGR)
Website
www.integer.net
LinkedIn
Company page

Recent activity at Integer Holdings Corporation

  • : Integer Holdings Corp Announces Stockholder Approval for Upcoming Acquisition
  • : SEC 8-K (7.01): On October 21, 2026, the Company announced through a press release that stockholder approval for an unspecified Transaction has been obtained. The transaction is expected to close by the end of 2026, pending the satisfaction or waiver of customary closing conditions. The press release, which is attached as Exhibit 99.1, indicates that the completion of the Transaction is subject to regulatory approvals and could face risks, including potential litigation related to the Merger Agreement. This announcement is significant as it confirms a critical step in the transaction process, thereby impacting the company's strategic direction and shareholder value.
  • : SEC 8-K (8.01): On October 2, 2026, Integer Holdings Corporation announced that its 2.125% Convertible Senior Notes due 2028 have become convertible at the option of the holders during the calendar quarter ending December 31, 2026. This allows holders to convert the Notes into cash, shares of the Company’s common stock, or a combination thereof, depending on the Company's election concerning the excess principal amount. The announcement is significant as it outlines the conversion rights affecting the Company’s capital structure and could impact stockholder value. The conversion capability applies to the entire quarter ending December 31, 2026, and further details are provided in the attached press release (Exhibit 99.1) and notification notice (Exhibit 99.2).
  • : SEC 8-K (8.01): Integer Holdings Corporation announced that it has received early termination of the waiting period for the consummation of its merger with Armstrong Parent, Inc. and Armstrong Bidco, Inc. on September 30, 2026. This early termination under the Hart-Scott-Rodino Antitrust Improvements Act satisfies a key condition for the merger, which is expected to close by the end of calendar year 2026. The transaction involves Integer becoming a wholly owned subsidiary of Parent, affiliated with Kohlberg Kravis Roberts & Co. L.P. Stockholder approval for the merger is scheduled for October 21, 2026, reinforcing the strategic partnership and anticipated growth post-merger.
  • : SEC 8-K (8.01):
  • : SEC 8-K (1.01): On August 2, 2026, Integer Holdings Corporation entered into a Material Definitive Agreement with Armstrong Parent, Inc. and Armstrong Bidco, Inc. regarding a merger agreement. The transaction entails Merger Sub merging with Integer Holdings, with Integer becoming a wholly owned subsidiary of Parent. Shareholders will receive $127 in cash for each share of common stock, with specific treatments for restricted stock units (RSUs) and performance stock units (PSUs) outlined in the agreement. The merger represents a strategic initiative by Kohlberg Kravis Roberts & Co. L.P. to directly acquire Integer's assets and business operations.
  • : SEC 8-K (7.01): On August 3, 2026, Integer Holdings Corporation announced via a press release that it has entered into an agreement and plan of merger with Armstrong Parent, Inc. and Armstrong Bidco, Inc. for its acquisition at a price of $127 per share, totaling an enterprise value of approximately $5.7 billion. This transaction involves Parent and Merger Sub, both affiliates of investment funds managed by Kohlberg Kravis Roberts & Co. L.P., a global investment firm. The filing includes a declaration of the intent to seek stockholder approval via a proxy statement to be filed with the SEC in the coming weeks, hence highlighting the strategic movement in the company's business operations and capital structure.
  • : Jim Stephens Appointed Executive Vice President of Special Projects at Integer Holdings Corporation
  • : SEC 8-K (5.02): On June 24, 2026, Integer Holdings Corporation's Compensation and Organization Committee approved changes to the compensation for Jim Stephens, transitioning him from President of Cardiac Rhythm Management & Neuromodulation to Executive Vice President of Special Projects, effective June 29, 2026. A letter agreement dated June 26, 2026, outlines that this new role will terminate on March 31, 2027, unless terminated earlier. If a Change of Control occurs before this termination and Mr. Stephens is still employed at that time, it will be treated as a termination without Cause for benefit purposes. He will not be eligible for incentive awards in 2027, but other employment terms remain unchanged.
  • : SEC 8-K (5.02): On June 24, 2026, Integer Holdings Corporation's Compensation and Organization Committee approved changes to the compensation of Jim Stephens, who is transitioning from President of Cardiac Rhythm Management & Neuromodulation to Executive Vice President of Special Projects, effective June 29, 2026. This new role is set to last until March 31, 2027, unless terminated earlier by Mr. Stephens or the Company. The decision reflects strategic adjustments in leadership roles to better align with corporate objectives.

Integer Holdings Corporation funding history

DateRoundAmount
Nov 2015Venture$247.2M

Leadership

  • Jim Stephens, Executive Vice President
  • Payman Khales, Chief Executive Officer
  • Sanjiv Arora, Vice President of Strategy
  • Lindsay Krause Blackwood, General Counsel

Verified email and direct lines for Integer Holdings Corporation’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

Integer Holdings Corporation files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Integer Holdings Corporation in the news

Companies similar to Integer Holdings Corporation

About Integer Holdings Corporation: questions and answers

What does Integer Holdings Corporation do?

Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets.

Where is Integer Holdings Corporation headquartered?

Integer Holdings Corporation is headquartered in Plano, Texas, United States.

How many employees does Integer Holdings Corporation have?

Integer Holdings Corporation has about 11,000 employees.

Has Integer Holdings Corporation raised funding?

Yes. Fundz has recorded 1 funding event for Integer Holdings Corporation. The most recent, $247.2M, was in Nov 2015.

Who leads Integer Holdings Corporation?

Jim Stephens is an Executive Vice President at Integer Holdings Corporation.

What is the latest news on Integer Holdings Corporation?

On Oct 21, 2026, Integer Holdings Corp Announces Stockholder Approval for Upcoming Acquisition

Is Integer Holdings Corporation a public company?

Yes. Integer Holdings Corporation is publicly traded under the ticker ITGR.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Integer Holdings Corporation across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.